Ken Research’s Primary Sclerosing
Cholangitis Global Clinical Trials Review, H1, 2018 gives an overview of the global
clinical trials landscape and top-level data related to clinical trials by
Region, Country (G7 and E7), Trial Status, trial Phase, Sponsor type and End
point status. The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company and all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for
their non-accomplishments. It provides enrolment trends for the past five years
and the latest news relating to these trials for the past three months. The
companies involved in the clinical trials of Primary Sclerosing Cholangitis are
Hightide Biopharma Pty Ltd, Gilead Sciences Inc, Dr.
Falk Pharma GmbH, Allergan Plc, Shire Plc, Acorda Therapeutics Inc, Celgene
Corp, ChemomAb Ltd, ChemoCentryx Inc and Axcan Pharma Inc. The report will enhance the decision- making
capabilities and helps to create an effective counter strategy to gain
competitive advantage and helps in identifying locations to conducting these
trials.
Primary
Sclerosing Cholangitis (PSC) is a chronic disease that attacks bile ducts. Bile
is secreted by the liver. For those affected with PSC, the bile ducts get inflamed
and scarred and becomes blocked. This leads to the bile getting stored up in
the liver which damages the liver cells and causes cirrhosis. As cirrhosis
progresses and the scar tissues in the liver increase, the liver loses its
ability to perform its function. PSC advances in a slow pace and patients may
have this disease for years before the symptoms show up.
Clinical
trials are conducted in medical research labs to find better ways to prevent
and treat diseases or diagnose them. They give solutions on the medical approaches
suitable for certain illness to a certain group of people specifically. These
trials help a great deal in making healthcare decisions. Since they answer
scientific questions, these trials are required to be carried on under strict
and scientific standards that protect the interests of the patients. They are
also the final and the most important stage of clinical research and
development. Clinical trials for drugs take place in four phases- first, they
test an experimental drug on a few people and study the effects; second, they
test the drug on more people than in Phase 1 which may extend up to years;
third, they include many other participants to test for safety and efficacy and
study the side effects deeper than in Phase 2; fourth, getting approval of the
usage of drug from the relevant authority.
To know more,
click on the link below:
https://www.kenresearch.com/healthcare/pharmaceuticals/primary-sclerosing-cholangitis/154919-91.html
Related Reports :-
+91-9015378249
